 |
ArchiveMember Q&A: TevaPosted by Jim Ambrosio at 1:06PM on June 21st
Q) Can you give your thoughts on Teva Pharmaceutical Industries (TEVA)? A) We profiled generic drug maker Teva in late March when the stock was on a roll, concluding by saying, “Given its strong earnings power and cash flow, the stock isn’t overly expensive,…  Debt Jitters Strike Wall Street (MA, PFE, CVS, TEVA, NTRI)Posted by Jim Ambrosio at 4:53PM on May 4th
After yesterday’s rally, stocks took it on the chin today as fears over European debt problems crept back into investors’ minds. Nothing materially changed from yesterday to today, but pushback from the Greek populace and concerns that the debt contagion… Yale Endowment’s Top Q4 Picks Crushing Harvard’s Winners (OPEN, XTXI, WWW, OEF, BIOD, EWM, RSX, TEVA, BJS, BRK.A, BRK.B)Posted by Owen Vater at 12:28PM on April 9th
Few college endowments are watched as closely as those of Harvard and Yale, whose Ivy League pedigrees and esteemed alumni have helped the institutions build multi-billion dollar nest eggs. As of the most recent regulatory filings from the end of… Trading Wizard Cohen Adds to His Billions (SLXP, LINTA, GRMN, ADSK, CVA, HK, BRCD, JPM, WFC, TEVA, TYC)Posted by Jason Smith at 11:10AM on April 7th
SAC Capital’s Steven Cohen was one of 2009’s top earners, netting another ten-figure payday after rebounding from the flagship fund’s first ever annual loss. Many hedge fund managers would have been happy to lose just -19% during the market’s slide in… Bulls Still Hanging Tough, but Potential Speedbumps Ahead (NKE, GES, GME, TEVA, PFE, CIGX)Posted by Geoff Seiler at 4:57PM on March 18th
While the S&P was down a sliver, stocks continue to trade well, with the Dow now up 8-straight days. Following an approximately -8% dip earlier this year, stocks have been on a steady, slow rise with little volatility. There could… A Slew of New Deals Move Pharma StocksPosted by Owen Vater at 10:17AM on December 21st
Some big names got into the action on Monday. A nearly $2 billion buyout and three new agreements are sending select healthcare stocks soaring today, and some big names are in the mix. A look at the Big Pharmaceutical Stocks Index’s… Harvard Endowment Favors Mix of ETFs, International NamesPosted by Max Magee at 9:59AM on November 19th
Though the market downturn was devastating for the Harvard endowment, 2009’s extend rally has kept the more dire forecasts from being realized. According to Bloomberg, the value of Harvard’s investments fell by -27.3% in the year ended June 30, not as… Teva Gains on Earnings, Denies Michael Jackson ConnectionPosted by Owen Vater at 12:23PM on July 28th
Teva Pharmaceuticals (TEVA) profits beat expectations in the second quarter, despite slipping year-over-year. Israeli generic pharmaceutical giant Teva announced second-quarter earnings of $521 million or 58 cents a share, down slightly from last year when the company made $533 million or 63… Harvard Looks to ETFs, Emerging Markets to Fuel TurnaroundPosted by Max Magee at 9:50AM on May 14th
With the Harvard endowment still reeling from a calamitous 2008, the school’s money managers made a number of moves in Q1 with a bias towards emerging markets. The market massacre of 2008 had wide-ranging implications. The carnage on both Wall Street…  |
|
Follow us on
  |
| Home | Find | Research | Track | Register | My Account | Logout | Web site design by LightMix |
| © 2007-2013 Indie research Corp. All rights reserved. |